Results 211 to 220 of about 14,118,684 (408)
Self-oriented affective empathy is associated with increased negative affect. [PDF]
Hülsemann MJ+16 more
europepmc +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
Dynamic Complexity of Positive and Negative Affect in NSSI - A Daily Diary Study. [PDF]
Bruckbauer-Schwed M+3 more
europepmc +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
A naturalistic examination of the perceived effects of cannabis on negative affect.
C. Cuttler+2 more
semanticscholar +1 more source
A Review of Chronic Wounds and Their Impact on Negative Affect, Cognition, and Quality of Life. [PDF]
Redmond MC, Gethin G, Finn DP.
europepmc +1 more source
Negatively charged residues adjacent to IFM motif in the DIII–DIV linker of hNaV1.4 differentially affect slow inactivation [PDF]
Isabelle J McCollum+4 more
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Negative affect in fibromyalgia in comparison to controls: A cross-sectional investigation of risk and protective factors. [PDF]
Sygel M+2 more
europepmc +1 more source